NASDAQ Framework: Astrana Health Inc.

Technology-powered healthcare management company 1.
1: Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California. View Source
Astrana Health Inc., headquartered in Alhambra, California, is a leading provider-centric, technology-powered healthcare company that enables providers to deliver accessible, high-quality, and high-value care to all. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that empowers providers to participate successfully in value-based care arrangements. Serving over 10,000 providers and 1.0 million Americans, Astrana's subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), accountable care organizations (ACOs), and care delivery entities across primary, multi-specialty, and ancillary care 23.
2: About Astrana Health Astrana is a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner. Headquartered in Alhambra, California, Astrana serves over 10,000 providers and 900,000 Americans in value-based care arrangements. Its subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), accountable care organizations (ACOs), and care delivery entities across primary, multi-specialty, and ancillary care. For more information, please visit www.astranahealth.com. View Source3: Headquartered in Alhambra, California, Astrana serves over 10,000 providers and 1.0 million Americans in value-based care arrangements. Its subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), accountable care organizations (ACOs), and care delivery entities across primary, multi-specialty, and ancillary care. For more information, please visit www.astranahealth.com. View Source
UNKNOWN

The provided facts do not specify whether Astrana Health Inc. is still led by its founders or if the founders are heavily involved. The information given includes details about the company's leadership changes and current executives but does not mention the founders' involvement 4.
4: On February 26, 2024 the Company changed its name from Apollo Medical Holdings, Inc. to Astrana Health, Inc. Alongside the corporate name change, the Company's common stock is trading under the new symbol "ASTH" on the NASDAQ. In November 2023, the Company entered into an Asset and Equity Purchase Agreement (the "Purchase Agreement") to acquire the partnership interests of Advanced Health Management Systems, L.P. ("AHMS") and certain assets of Community Family Care Medical Group IPA, Inc. ("CFC"), which acquisitions the Company expected would occur in two separate closings. In November 2023, AHM (as defined below) also entered into a Stock Purchase Agreement (the "I Health Purchase Agreement") to purchase 25% of the outstanding shares of common stock of I Health, Inc. ("I Health"). On January 31, 2024, the first closing under the Purchase Agreement occurred, and the Company completed its acquisition of CFC's assets. CFC IPA manages the healthcare of over 200,000 members in the Los Angeles, California area, serving patients across Medicare, Medicaid, and Commercial payers. The Company expects to complete the second closing under the Purchase Agreement and acquire the outstanding general and limited partnership interests of AHMS during the first quarter of 2024, subject to obtaining required regulatory approvals. It is currently expected that the I Health Purchase Agreement closing will occur during the first quarter of 2024. On January 29, 2024, the Company announced its strategic long-term partnership with BASS Medical Group, one of the largest multi-specialty medical groups in the Greater San Francisco Bay Area. Together, the two organizations will aim to bring high-quality care via value-based arrangements to patients of all insurance types, including Medicare, Medicaid, ACA Marketplace, and Commercial. Astrana has provided BASS Medical Group with a $20 million senior secured promissory note ("BASS secured promissory note") which is intended to be used, in partnership with Astrana, to continue to grow their footprint and invest in high-quality, high-value, and accessible primary and multi-specialty care for communities across California. The BASS secured promissory note matures on January 11, 2031 and has an interest rate per annum equal to 2.9% plus the Secured Overnight Financing Rate as administered by the Federal Reserve Bank of New York (or a successor administrator) compounded annually. Effective January 19, 2024, the Company had the following leadership changes: Thomas S. Lam, M.D., M.P.H., previously Co-Chief Executive Officer and President and a director, was appointed Vice Chairman of the Board; Brandon K. Sim, M.S., previously Co-Chief Executive Officer, was appointed Chief Executive Officer and President; and Chan Basho, M.B.A., previously Chief Financial Officer and Chief Strategy Officer, was appointed Chief Financial Officer and Chief Operating Officer. In addition, Dinesh Kumar, M.D., was appointed Chief Medical Officer effective January 23, 2024. On January 1, 2024, the Company's Employee Stock Purchase Plan ("ESPP") came into effect. The Company's ESPP allows eligible employees to contribute up a portion of their eligible earnings toward the semi-annual purchase of the Company's common stock at a discounted price, subject to an annual maximum dollar amount. On January 1, 2024, in addition to participating in the ACO REACH Model, one of our other ACOs will participate in the Medicare Shared Savings Program ("MSSP"). The MSSP was created to promote accountability and improve coordination of care for Medicare beneficiaries. Unlike the ACO REACH Program, CMS continues to pay participant and preferred providers on a fee-for-service basis for Medicare covered services provided to MSSP Aligned Beneficiaries. Our shared savings or losses in managing our beneficiaries are generally determined on an annual basis after reconciliation with CMS. View Source
LOW RISK

Astrana Health Inc. is considered low risk due to its strong financial performance and positive outlook. The company reported significant growth in net income, up 34% from $45.2 million to $60.7 million, and an increase in total revenue by 21% from $1,144.2 million to $1,386.7 million 5. Additionally, Astrana Health has shown robust financial health indicators, such as a positive EBITDA margin and free cash flow 67. The company also has a favorable market position, with institutional investors holding a significant stake, implying confidence in its financial stability 89.
5: Total revenue of $1,386.7 million, up 21% from $1,144.2 million Care Partners revenue of $1,300.1 million, up 24% from $1,051.5 million Net income attributable to Astrana of $60.7 million, up 34% from $45.2 million Earnings per share — diluted ("EPS — diluted") of $1.29, up 30% from $0.99 per share Adjusted EBITDA(1) of $146.6 million, up 5% from $140.0 million View Source6: Astrana has a significant presence in Southern California, where the CY25 rate updates showed a 5% increase in Los Angeles County compared to a nationwide decline of 0.16%. Astrana Health’s lower-than-average RAF score could be advantageous as the company improves its risk coding. Most investor meetings focused on Astrana’s differentiation from other VBC/Payvider companies, highlighting its profitability (~10% adjusted EBITDA margin) and positive free cash flow. View Source7: Jailendra Singh has given his Buy rating due to a combination of factors including Astrana Health’s distinctive care model, which has effectively tapped into the “pent-up” demand within the value-based care industry. Singh highlights the company’s impressive growth in revenue and maintains a positive outlook on the company’s EBITDA margin and free cash flow, which are indicators of strong financial health. Furthermore, Singh notes that Astrana Health has a robust full delegation model, which bolsters the company’s capability to manage utilization and provides clearer visibility into future trends. View Source8: As you can see, institutional investors have a fair amount of stake in Astrana Health. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Astrana Health's earnings history below. Of course, the future is what really matters. View Source9: Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 26.37 percent of Astrana Health Inc. shares are owned by insiders, and 44.72 percent are held by financial institutions. View Source
NO

The provided facts do not indicate that Astrana Health Inc. is launching any new product offerings. The information focuses on partnerships, financial results, and strategic acquisitions but does not mention any new products being introduced 1011121314.
10: Astrana Health and Elation Health Form Nationwide Partnership to Expand Sustainable Support Infrastructure for Primary Care Physicians PR Newswire Jul 17, 2024 8:10pm Astrana Health and Anthem Blue Cross Establish Partnership to Deliver High-Quality Coordinated Care PR Newswire Jul 15, 2024 12:30pm Astrana Health, Inc. to Participate in Upcoming Investor Conferences PR Newswire May 28, 2024 8:05pm Astrana Health, Inc. to Participate in Upcoming Investor Conference PR Newswire May 13, 2024 8:05pm Astrana Health, Inc. Reports First Quarter 2024 Results PR Newswire May 7, 2024 8:10pm Astrana Health, Inc. Schedules 2024 First Quarter Financial Results Release and Conference Call PR Newswire Apr 30, 2024 8:11pm View Source11: On February 26, 2024 the Company changed its name from Apollo Medical Holdings, Inc. to Astrana Health, Inc. Alongside the corporate name change, the Company's common stock is trading under the new symbol "ASTH" on the NASDAQ. In November 2023, the Company entered into an Asset and Equity Purchase Agreement (the "Purchase Agreement") to acquire the partnership interests of Advanced Health Management Systems, L.P. ("AHMS") and certain assets of Community Family Care Medical Group IPA, Inc. ("CFC"), which acquisitions the Company expected would occur in two separate closings. In November 2023, AHM (as defined below) also entered into a Stock Purchase Agreement (the "I Health Purchase Agreement") to purchase 25% of the outstanding shares of common stock of I Health, Inc. ("I Health"). On January 31, 2024, the first closing under the Purchase Agreement occurred, and the Company completed its acquisition of CFC's assets. CFC IPA manages the healthcare of over 200,000 members in the Los Angeles, California area, serving patients across Medicare, Medicaid, and Commercial payers. The Company expects to complete the second closing under the Purchase Agreement and acquire the outstanding general and limited partnership interests of AHMS during the first quarter of 2024, subject to obtaining required regulatory approvals. It is currently expected that the I Health Purchase Agreement closing will occur during the first quarter of 2024. On January 29, 2024, the Company announced its strategic long-term partnership with BASS Medical Group, one of the largest multi-specialty medical groups in the Greater San Francisco Bay Area. Together, the two organizations will aim to bring high-quality care via value-based arrangements to patients of all insurance types, including Medicare, Medicaid, ACA Marketplace, and Commercial. Astrana has provided BASS Medical Group with a $20 million senior secured promissory note ("BASS secured promissory note") which is intended to be used, in partnership with Astrana, to continue to grow their footprint and invest in high-quality, high-value, and accessible primary and multi-specialty care for communities across California. The BASS secured promissory note matures on January 11, 2031 and has an interest rate per annum equal to 2.9% plus the Secured Overnight Financing Rate as administered by the Federal Reserve Bank of New York (or a successor administrator) compounded annually. Effective January 19, 2024, the Company had the following leadership changes: Thomas S. Lam, M.D., M.P.H., previously Co-Chief Executive Officer and President and a director, was appointed Vice Chairman of the Board; Brandon K. Sim, M.S., previously Co-Chief Executive Officer, was appointed Chief Executive Officer and President; and Chan Basho, M.B.A., previously Chief Financial Officer and Chief Strategy Officer, was appointed Chief Financial Officer and Chief Operating Officer. In addition, Dinesh Kumar, M.D., was appointed Chief Medical Officer effective January 23, 2024. On January 1, 2024, the Company's Employee Stock Purchase Plan ("ESPP") came into effect. The Company's ESPP allows eligible employees to contribute up a portion of their eligible earnings toward the semi-annual purchase of the Company's common stock at a discounted price, subject to an annual maximum dollar amount. On January 1, 2024, in addition to participating in the ACO REACH Model, one of our other ACOs will participate in the Medicare Shared Savings Program ("MSSP"). The MSSP was created to promote accountability and improve coordination of care for Medicare beneficiaries. Unlike the ACO REACH Program, CMS continues to pay participant and preferred providers on a fee-for-service basis for Medicare covered services provided to MSSP Aligned Beneficiaries. Our shared savings or losses in managing our beneficiaries are generally determined on an annual basis after reconciliation with CMS. View Source12: Astrana Health and Elation Health Form Nationwide Partnership to Expand Sustainable Support Infrastructure for Primary Care Physicians Astrana Health, Inc. (together with its subsidiaries and affiliated entities, "Astrana") (NASDAQ: ASTH), a leading provider-centric,... View Source13: In conjunction with the announcement of this partnership, Astrana and Anthem Blue Cross have opened their first collaborative care clinic located at 11236 Whittier Blvd in Whittier, California to serve residents of Whittier and the surrounding area. The new Astrana Care and Anthem Blue Cross facility, which will exclusively serve Anthem Blue Cross and Allied Pacific IPA members with an HMO health insurance plan, is equipped with state-of-the-art medical technology and offers a wide range of services, with a focus on comprehensive health assessments, preventive care, and chronic disease management. Designed with patient comfort and accessibility in mind, the inaugural collaborative clinic aims to provide exceptional care and a superior consumer experience. View Source14: ALHAMBRA, Calif., April 2, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced it has completed the acquisition relating to Community Family Care Medical Group on March 31, 2024 by closing both the second closing under the Asset and Equity Purchase Agreement and the closing under the Stock Purchase Agreement, which includes  the CFC Health Plan ("HP") and CFC's management services organization ("MSO") entities. View Source
Astrana Health Inc.'s product roadmap and expansion strategy for 2024 through to 2026 focuses on scaling its unique care model, expanding its membership base across existing and new geographies, and increasing its accountability and risk in value-based care contracts. The company aims to empower providers to achieve superior patient outcomes and execute strategic acquisitions to accelerate growth. Recent partnerships, such as those with Anthem Blue Cross and BASS Medical Group, highlight Astrana's commitment to expanding access to high-quality care and addressing social and health inequities. Additionally, Astrana projects significant revenue growth, expecting a 25%-30% increase over the next few years, with EBITDA growth aligning closely with revenue growth, particularly if mergers and acquisitions are part of the strategy [fERROR]Astrana Health Inc.'s product roadmap and expansion strategy for 2024 through to 2026 focuses on scaling its unique care model, expanding its membership base across existing and new geographies, and increasing its accountability and risk in value-based care contracts. The company aims to empower providers to achieve superior patient outcomes and execute strategic acquisitions to accelerate growth. Recent partnerships, such as those with Anthem Blue Cross and BASS Medical Group, highlight Astrana's commitment to expanding access to high-quality care and addressing social and health inequities. Additionally, Astrana projects significant revenue growth, expecting a 25%-30% increase over the next few years, with EBITDA growth aligning closely with revenue growth, particularly if mergers and acquisitions are part of the strategy [fERROR][fERROR]Astrana Health Inc.'s product roadmap and expansion strategy for 2024 through to 2026 focuses on scaling its unique care model, expanding its membership base across existing and new geographies, and increasing its accountability and risk in value-based care contracts. The company aims to empower providers to achieve superior patient outcomes and execute strategic acquisitions to accelerate growth. Recent partnerships, such as those with Anthem Blue Cross and BASS Medical Group, highlight Astrana's commitment to expanding access to high-quality care and addressing social and health inequities. Additionally, Astrana projects significant revenue growth, expecting a 25%-30% increase over the next few years, with EBITDA growth aligning closely with revenue growth, particularly if mergers and acquisitions are part of the strategy [fERROR][fERROR][fERROR]Astrana Health Inc.'s product roadmap and expansion strategy for 2024 through to 2026 focuses on scaling its unique care model, expanding its membership base across existing and new geographies, and increasing its accountability and risk in value-based care contracts. The company aims to empower providers to achieve superior patient outcomes and execute strategic acquisitions to accelerate growth. Recent partnerships, such as those with Anthem Blue Cross and BASS Medical Group, highlight Astrana's commitment to expanding access to high-quality care and addressing social and health inequities. Additionally, Astrana projects significant revenue growth, expecting a 25%-30% increase over the next few years, with EBITDA growth aligning closely with revenue growth, particularly if mergers and acquisitions are part of the strategy [fERROR][fERROR][fERROR][fERROR]Astrana Health Inc.'s product roadmap and expansion strategy for 2024 through to 2026 focuses on scaling its unique care model, expanding its membership base across existing and new geographies, and increasing its accountability and risk in value-based care contracts. The company aims to empower providers to achieve superior patient outcomes and execute strategic acquisitions to accelerate growth. Recent partnerships, such as those with Anthem Blue Cross and BASS Medical Group, highlight Astrana's commitment to expanding access to high-quality care and addressing social and health inequities. Additionally, Astrana projects significant revenue growth, expecting a 25%-30% increase over the next few years, with EBITDA growth aligning closely with revenue growth, particularly if mergers and acquisitions are part of the strategy [fERROR][fERROR][fERROR][fERROR].